Mutual of America Capital Management LLC Decreases Stock Position in Itron, Inc. $ITRI

Mutual of America Capital Management LLC lessened its holdings in shares of Itron, Inc. (NASDAQ:ITRI) by 10.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,856 shares of the scientific and technical instruments company’s stock after selling 710 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Itron were worth $771,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of ITRI. Invesco Ltd. lifted its stake in Itron by 2.7% in the 1st quarter. Invesco Ltd. now owns 2,310,769 shares of the scientific and technical instruments company’s stock worth $242,076,000 after purchasing an additional 59,962 shares in the last quarter. Amundi raised its position in shares of Itron by 18.4% in the first quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company’s stock worth $97,313,000 after buying an additional 144,361 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Itron by 129.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company’s stock worth $76,713,000 after buying an additional 413,487 shares in the last quarter. Wellington Management Group LLP boosted its stake in Itron by 15.2% during the first quarter. Wellington Management Group LLP now owns 384,152 shares of the scientific and technical instruments company’s stock valued at $40,244,000 after buying an additional 50,789 shares during the period. Finally, PGGM Investments grew its position in Itron by 6.3% during the second quarter. PGGM Investments now owns 362,558 shares of the scientific and technical instruments company’s stock worth $47,724,000 after buying an additional 21,381 shares in the last quarter. Institutional investors own 96.19% of the company’s stock.

Analyst Ratings Changes

ITRI has been the topic of several research reports. Johnson Rice cut shares of Itron from a “buy” rating to an “accumulate” rating in a research report on Friday, August 1st. Guggenheim reaffirmed a “buy” rating and set a $155.00 price target (up previously from $133.00) on shares of Itron in a research note on Monday, July 14th. Roth Capital upped their price objective on Itron from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. Stephens reissued an “equal weight” rating and set a $130.00 price objective on shares of Itron in a report on Tuesday, October 7th. Finally, JPMorgan Chase & Co. boosted their target price on Itron from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Thursday, October 16th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $138.10.

Itron Price Performance

Shares of ITRI stock opened at $136.11 on Tuesday. The business’s fifty day moving average is $125.05 and its 200 day moving average is $122.54. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. The stock has a market cap of $6.22 billion, a price-to-earnings ratio of 23.27, a PEG ratio of 0.75 and a beta of 1.48. Itron, Inc. has a twelve month low of $90.11 and a twelve month high of $140.04.

Itron (NASDAQ:ITRI) last announced its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.29. Itron had a net margin of 11.05% and a return on equity of 19.69%. The business had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. During the same quarter last year, the firm earned $1.21 earnings per share. The business’s revenue for the quarter was down .4% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Research analysts expect that Itron, Inc. will post 5.33 EPS for the current fiscal year.

Insider Activity

In other news, SVP Christopher E. Ware sold 351 shares of Itron stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $43,983.81. Following the completion of the transaction, the senior vice president owned 19,117 shares of the company’s stock, valued at $2,395,551.27. The trade was a 1.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Joan S. Hooper sold 970 shares of the firm’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $121,550.70. Following the sale, the chief financial officer owned 88,394 shares of the company’s stock, valued at approximately $11,076,652.14. This represents a 1.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 3,037 shares of company stock valued at $380,566. 1.45% of the stock is currently owned by insiders.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.